About
Patrick Clayton, PhD, is a strategic biotech advisor with a strong foundation in academic research and industry experience. He has served in strategic roles at organizations including MD Anderson, Hummingbird Bioscience, and BostonGene, driving impactful work across intellectual property strategy, licensing, business development, and competitive intelligence. Patrick combines deep scientific knowledge with business insight to help early-stage and growth-stage biotech companies navigate critical inflection points.